Annexon Inc.

World Rank (Aug-2026)

9234

Market Cap (Aug-2026)

1.003 Billion USD

Market Cap (Mar-08-2026)

0.617 Billion USD

World Rank (Jan-05-2024)

14,389

Market Cap (Jan-05-2024)

0.375 Billion USD

World Rank (Jul-30-2023)

18,916

Market Cap (Jul-30-2023)

0.170 Billion USD

World Rank (Jan-07-2022)

16,216

Market Cap (Jan-07-2022)

0.319 Billion USD

World Rank (Jan-01-2021)

8,136

Market Cap (Jan-01-2021)

0.955 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

ANNX

Employee Count

38

Employee Count as of Date

As on September 2020

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Operating Income in USD

-216 Million USD

Annual Net Income in USD

-207 Million USD

Annual Results for Period Ending

For year ending December-2025

Total Assets in USD

278 Million USD

Total Liabilities in USD

66 Million USD

Total Equity in USD

212 Million USD

Balance Sheet for Period Ending

As of December-2025

Business Sector

Company Website

Yahoo

Company Profile

Annexon Biosciences is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing breakthrough therapeutics for autoimmune and neurodegenerative disease. It is having 38 employees as on September 2020. The headquarters is in USA.

Founded Year

2011

IPO Year

2020

Stock Exchange

Nasdaq

Nasdaq Sector

Health Care

Nasdaq Industry

Biotechnology: Pharmaceutical Preparations